Font Size: a A A
Keyword [Thrombin activatable fibrinolysis inhibitor]
Result: 1 - 20 | Page: 1 of 2
1. Effects Of Homocysteine On Vascular Endothelial Cells: Induction Of Apoptosis, Regulation Of TAFI And TFPI Expression, And Proteomic Alteration
2. Effects Of Thrombin-activable Fibrinolysis Inhibitor And Hirudin On Fibrinolysis
3. Study On Molecular Mechanisms Of Glanzmann Thrombasthenia And Antithrombotic Mechanisms Of Holothurian Glycosaminoglycan Extracted From Sea Cucumber
4. Changes Of Plasma Thrombin-Activatable Fibrinolysis Inhibitor In The Senile With Unstable Angina Pectoris And The Influence Of Low-Molecular-Weight Heparin
5. Studies On The Thrombin Activatable Fibrinolysis Inhibitor Of Coronary Atherosclerotic Heart Disease
6. Investigation Of TAFI Level And Mechanism Of Action In The Process Of Atherosclerosis In Rats.
7. Low Molecular Weight Heparin On Coagulation And Fibrinolysis System Of Patients With Acute Coronary Syndrome: Clinical Study Of Its Effects, Avalability
8. Effect Of Baicalin On Atherosclerosis And TAFI Level In Rabbits
9. Study On The Association Of The Gene Polymorphism Of Thrombin Activatable Fibrinolysis Inhibitor With Coronary Atherosclerotic Heart Disease
10. Correlation Of Metablic Parameters Of Non-Obesity Type 2 Diabetic Patients To Functions Of TAFI, PAI-1 And VWF
11. Study Of The Relativity Between Thrombin-activatable Fibrinolysis Inhibtor And Stroke
12. Study On The The Association Of Genetic Variations In Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Encoding Region And The Risk Of Type 2 Diabetes Mellitus
13. The Expression Of TAFI In The Patient With Polycystic Ovary Syndrome
14. Association Between Thrombin Activatable Fibrrinolysis Inhibitor And Breast Cancer
15. Study On The Thrombin-activatable Fibrinolysis Inhibitor In Venous Thrombolism
16. Expression Of TAFI In Cervical Squamous Cell Carcinoma Tissues With And Without Pelvic Lymph Node Metastasis And Its Clinical Significance
17. The Relationship Between Thrombin Activatable Fibrinolysis Inhibitor And Stroke: A Case-control Study
18. The Relationship Between Thrombin Activatable Fibrinolysis Inhibitor And Essential Hypertension In The Elderly:A Case-control Study
19. Study On Correlation Between Thrombin Activatable Fibrinolysis Inhibitor And Acute Ischemic Stroke
20. Modeling of fibrinolysis and thrombin-activatable fibrinolysis inhibitor
  <<First  <Prev  Next>  Last>>  Jump to